Mingrone Geltrude
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mingrone, Geltrude
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Recruiting
3
10000
Europe, Canada, US, RoW
Retatrutide, LY3437943, Placebo
Eli Lilly and Company
Overweight and Obesity
02/29
02/29
PASIPHY, NCT05928390: Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia

Recruiting
2
72
Europe, US
Pasireotide Diaspartate, Pasireotide
RECORDATI GROUP
Post-Bariatric Hypoglycemia
04/25
04/26
CONNECT, NCT04653103: NASH in Subjects With Different Classes of Obesity

Active, not recruiting
N/A
500
Europe
Liver biopsy
Catholic University of the Sacred Heart
NASH - Nonalcoholic Steatohepatitis, NAFLD, Obesity, Obesity, Morbid
01/21
01/23
CROSS-CO19, NCT05736900: Counter-Regulatory Hormonal and Stress Systems in Patients With COVID-19

Completed
N/A
200
Europe
Blood sampling
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
COVID-19
02/21
06/21
CoV-miR, NCT05739513: A Specific miRNA Encoded by SARS-CoV-2 as a Diagnostic Tool to Predict Disease Severity in COVID-19 Patients

Completed
N/A
120
Europe
miRNA analysis in plasma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
COVID-19
07/21
07/21
NCT05755321: From Skin Fibroblasts to Neural Stem Cells to Investigate in Vitro the Impact of Diabetes on Adult Neurogenesis

Active, not recruiting
N/A
40
Europe
Skin biopsy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2 in Obese, Diabetes Mellitus Type 2 in Nonobese, Obesity, Cognitive Dysfunction, Metabolism Disorder
04/23
05/23
FLAMES, NCT06374875: Fibrosis Lessens After Metabolic Surgery

Not yet recruiting
N/A
120
Europe, Canada, US, RoW
Metabolic surgery, Bariatric surgery, Roux-en-Y Gastric Bypass (RYGB), Sleeve Gastrectomy (SG), Incretin-Based Therapy, Glucagon-like Peptide-1 Receptor Agonist
Ali Aminian
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis, Obesity
05/29
12/29
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes

Recruiting
N/A
320
Europe, US
Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)
Fractyl Health Inc.
Type 2 Diabetes
06/24
01/26
FRIN, NCT05798702: Fibrosis Reduction in Non Alcoholic Steatohepatitis

Active, not recruiting
N/A
20
Europe
roux -en-y- gastric bypass, intensive life style modification
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
NASH With Fibrosis, Weight Loss, Bariatric Surgery Candidate
09/25
09/26

Download Options